1) Akagi H, Kumar TM:Lesson of the week:Akashisia:Overlooked at a cost. BMJ 324:1506-1507, 2002
2) Baldassano CF, Truman CJ, Nierenberg A, et al:Akathisia:Review and case report following paroxetine treatment. Compr Psychiatry 37:122-124, 1996
3) Burke RE, Kang UJ, Jankovic J, et al:Tartive akathisia:An analysis of clinical features and response to open therapeutic trials. Mov Disord 4:157-175, 1989
4) Fergusson D, Doucette S, Glass KC, et al:Association between suicide attempts and selective serotonin reuptake inhibitors:Systematic review of randomised controlled trials. BMJ 330:396, 2005
5) Hansen L:Fluoxetine dose-increment related akathisia in depression:Implications for clinical care, recognition and management of selective serotonin reuptake inhibitor-induced akathisia. J Psychopharmacol 17:451-452, 2003
6) 久保田正春,矢後知規,神庭重信:Amoxapineにfluoxetineを併用した後にアカシジアが生じた1例.精神科治療学 14:1397-1401,1999
7) Lancon C, Bernard D, Bougerol T:Fluoxetine, akathisia and suicide. Encephale 23:218-223, 1997
8) Lavine MR, Mendelowitz A, Block SH:Adverse reaction to high-dose fluoxetine. J Clin Psychopharmacol 13:452-453, 1993
9) Olivera AA:A case of paroxetine-induced akathisia. Biol Psychiatry 39:910, 1996
10) Rapoport A, Stein D, Grinshpoon A, et al:Akathisia and pseudoakathisia:Clinical observations and accelerometric recordings. J Clin Psychiatry 55:473-477, 1994
11) Rothschild AJ, Locke CA:Reexposure to fluoxetine after serious suicide attempts by three patients:The role of akathisia. J Clin Psychiatry 52:491-493, 1991
12) Schillevoort I, van Puijenbroke EP, de Boer A, et al:Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors:A case-control study using spontaneous reports. Int Clin Psychopharmacol 17:75-79, 2002